Rhumbline Advisers Pmv Pharmaceuticals, Inc. Transaction History
Rhumbline Advisers
- $105 Billion
- Q2 2024
A detailed history of Rhumbline Advisers transactions in Pmv Pharmaceuticals, Inc. stock. As of the latest transaction made, Rhumbline Advisers holds 23,035 shares of PMVP stock, worth $34,091. This represents 0.0% of its overall portfolio holdings.
Number of Shares
23,035
Previous 62,728
63.28%
Holding current value
$34,091
Previous $106,000
65.09%
% of portfolio
0.0%
Previous 0.0%
Shares
15 transactions
Others Institutions Holding PMVP
# of Institutions
101Shares Held
43.4MCall Options Held
500Put Options Held
100-
Orbimed Advisors LLC San Diego, CA6.48MShares$9.58 Million0.25% of portfolio
-
Arrow Mark Colorado Holdings LLC Denver, CO2.8MShares$4.15 Million0.06% of portfolio
-
Sio Capital Management, LLC New York, NY2.71MShares$4.01 Million1.64% of portfolio
-
Euclidean Capital LLC New York, NY2.63MShares$3.89 Million0.54% of portfolio
-
Alkeon Capital Management LLC New York, NY2.35MShares$3.47 Million0.01% of portfolio
About PMV Pharmaceuticals, Inc.
- Ticker PMVP
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 45,622,600
- Market Cap $67.5M
- Description
- PMV Pharmaceuticals, Inc., a precision oncology company, engages in the discovery and development of small molecule and tumor-agnostic therapies for p53 mutations in cancer. The company's lead product candidate is PC14586, a small molecule that corrects a p53 protein containing the Y220C mutation and restores wild-type p53 function. It is also d...